Evidence map›Paper›PMID 34224807›Full record

ArticleBiochimie2021

Cellular binding and uptake of fluorescent glucose analogs 2-NBDG and 6-NBDG occurs independent of membrane glucose transporters.

Kathryn E Hamilton, Miranda F Bouwer, Larry L Louters, Brendan D Looyenga

Open access · greenAbstract read
In one paragraph

Article in Biochimie, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 43 citations in OpenAlex.

  1. Review
  2. Review
  3. The metabolic profiles of cancer stem cells.Stem cell research & therapy · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Utilizing the apical-out enteroidsFrontiers in physiology · 2024
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Kathryn E HamiltonCalvin University, Department of Chemistry & Biochemistry, 1726 Knollcrest Circle SE, Grand Rapids, MI 49546, USA.
Miranda F BouwerCalvin University, Department of Chemistry & Biochemistry, 1726 Knollcrest Circle SE, Grand Rapids, MI 49546, USA.
Larry L LoutersCalvin University, Department of Chemistry & Biochemistry, 1726 Knollcrest Circle SE, Grand Rapids, MI 49546, USA.
Brendan D LooyengaCalvin University, Department of Chemistry & Biochemistry, 1726 Knollcrest Circle SE, Grand Rapids, MI 49546, USA. Electronic address: brendan.looyenga@gmail.com.
Calvin University · US

Funding

The Mechanism for the Acute Activation of GLUT1R15DK081931 · NIDDK · CALVIN UNIVERSITY · PI LOUTERS, LAURENCE LEON · 2009 to 2014
$600k
Cooperative Cellular Transformation by LRRK2 and MET in Renal NeoplasmsR15CA192094 · NCI · CALVIN UNIVERSITY · PI LOOYENGA, BRENDAN DAVID · 2015 to 2015
$296k
NCI NIH HHS R15 CA192094NIDDK NIH HHS R15 DK081931
6 · The paper itself

Abstract

The classical methods for determining glucose uptake rates in living cells involve the use of isotopically labeled 2-deoxy-d-glucose or 3-O-methyl-d-glucose, which enter cells via well-characterized membrane transporters of the SLC2A and SLC5A families, respectively. These classical methods, however, are increasingly being displaced by high-throughput assays that utilize fluorescent analogs of glucose. Among the most commonly used of these analogs are 2-NBDG and 6-NBDG, which contain a bulky 7-nitro-2,1,3-benzoxadiazol-4-yl-amino moiety in place of a hydroxy group on d-glucose. This fluorescent group significantly alters both the size and shape of these molecules compared to glucose, calling into question whether they actually enter cells by the same transport mechanisms. In this study, we took advantage of the well-defined glucose uptake mechanism of L929 murine fibroblasts, which rely exclusively on the Glut1/Slc2a1 membrane transporter. We demonstrate that neither pharmacologic inhibition of Glut1 nor genetic manipulation of its expression has a significant impact on the binding or uptake of 2-NBDG or 6-NBDG by L929 cells, though both approaches significantly impact [

Indexed as

4-Chloro-7-nitrobenzofurazanAnimalsBiological TransportCell LineDeoxyglucoseFibroblastsFluorescent DyesGlucosamineGlucoseGlucose Transporter Type 1Glucose Transport Proteins, FacilitativeHumansMice2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose4-Chloro-7-nitrobenzofurazan6-deoxy-N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)aminoglucoseDeoxyglucoseFluorescent DyesGlucosamineGlucoseGlucose Transporter Type 1Glucose Transport Proteins, FacilitativeSlc2a1 protein, mouse2-NBDG6-NBDGFluorescent analogGlucose uptakeGlut1

Identifiers

PMID34224807
PMCPMC8546778
OpenAlexW3182042391

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.